ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)

C130H144BClN16O8P4Pd — CID 160859803

IUPACethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)
SMILESCCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(-c3ccc(N4CCN(C)CC4)cc3)nc21.CCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(Cl)nc21.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C26H36N8O3.4C18H15P.C17H27BN2O2.C15H21ClN6O3.Pd/c1-3-37-22(35)18-34-19-28-23-25(27-8-9-32-14-16-36-17-15-32)29-24(30-26(23)34)20-4-6-21(7-5-20)33-12-10-31(2)11-13-33;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2)17(3,4)22-18(21-16)14-6-8-15(9-7-14)20-12-10-19(5)11-13-20;1-2-25-11(23)9-22-10-18-12-13(19-15(16)20-14(12)22)17-3-4-21-5-7-24-8-6-21;/h4-7,19H,3,8-18H2,1-2H3,(H,27,29,30);4*1-15H;6-9H,10-13H2,1-5H3;10H,2-9H2,1H3,(H,17,19,20);
InChIKeySKIISLOFCVCJNC-UHFFFAOYSA-N
MW2335.27 g/mol
LogP17.85
Rot. Bonds30

About ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)

ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) (PubChem CID 160859803) has the molecular formula C130H144BClN16O8P4Pd and a molecular weight of 2335.27 g/mol. Its IUPAC name is ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane).

Molecular Properties

Compound Nameethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)
PubChem CID160859803
Molecular FormulaC130H144BClN16O8P4Pd
Molecular Weight2335.27 g/mol
Exact Mass2332.91
IUPAC Nameethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)
SMILESCCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(-c3ccc(N4CCN(C)CC4)cc3)nc21.CCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(Cl)nc21.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C26H36N8O3.4C18H15P.C17H27BN2O2.C15H21ClN6O3.Pd/c1-3-37-22(35)18-34-19-28-23-25(27-8-9-32-14-16-36-17-15-32)29-24(30-26(23)34)20-4-6-21(7-5-20)33-12-10-31(2)11-13-33;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2)17(3,4)22-18(21-16)14-6-8-15(9-7-14)20-12-10-19(5)11-13-20;1-2-25-11(23)9-22-10-18-12-13(19-15(16)20-14(12)22)17-3-4-21-5-7-24-8-6-21;/h4-7,19H,3,8-18H2,1-2H3,(H,27,29,30);4*1-15H;6-9H,10-13H2,1-5H3;10H,2-9H2,1H3,(H,17,19,20);
InChIKeySKIISLOFCVCJNC-UHFFFAOYSA-N
XLogP17.85
TPSA220.22 Ų
H-Bond Donors2
H-Bond Acceptors24
Rotatable Bonds30
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002335.27
LogP ≤ 517.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)?
The IUPAC name of ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) (CID 160859803) is ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane).
What is the SMILES notation for ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)?
The canonical SMILES for ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) is CCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(-c3ccc(N4CCN(C)CC4)cc3)nc21.CCOC(=O)Cn1cnc2c(NCCN3CCOCC3)nc(Cl)nc21.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)?
The InChIKey is SKIISLOFCVCJNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H36N8O3.4C18H15P.C17H27BN2O2.C15H21ClN6O3.Pd/c1-3-37-22(35)18-34-19-28-23-25(27-8-9-32-14-16-36-17-15-32)29-24(30-26(23)34)20-4-6-21(7-5-20)33-12-10-31(2)11-13-33;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2)17(3,4)22-18(21-16)14-6-8-15(9-7-14)20-12-10-19(5)11-13-20;1-2-25-11(23)9-22-10-18-12-13(19-15(16)20-14(12)22)17-3-4-21-5-7-24-8-6-21;/h4-7,19H,3,8-18H2,1-2H3,(H,27,29,30);4*1-15H;6-9H,10-13H2,1-5H3;10H,2-9H2,1H3,(H,17,19,20);.
What are the key properties of ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane)?
ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) has a molecular weight of 2335.27 g/mol, XLogP of 17.85, 30 rotatable bonds, 2 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[2-chloro-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;ethyl 2-[2-[4-(4-methylpiperazin-1-yl)phenyl]-6-(2-morpholin-4-ylethylamino)purin-9-yl]acetate;1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine;palladium;tetrakis(triphenylphosphane) is sourced from PubChem (CID 160859803), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).